{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T19:26:44Z","timestamp":1794511604891,"version":"4.9.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ejmech.2023.115784","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T21:08:08Z","timestamp":1693516088000},"page":"115784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Discovery of NLRP3 inhibitors using machine learning: Identification of a hit compound to treat NLRP3 activation-driven diseases"],"prefix":"10.1016","volume":"260","author":[{"given":"Cheng","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Ran","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongfei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuxiao","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangren","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8993-4015","authenticated-orcid":false,"given":"Zhenming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115784_bib1","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1007\/s12035-023-03418-4","article-title":"Inhibition of the NLRP3 inflammasome activation\/assembly through the activation of the PI3K pathway by naloxone protects neural stem cells from ischemic condition","volume":"60","author":"Kim","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.ejmech.2023.115784_bib2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00281-015-0503-7","article-title":"Role of innate immune system in systemic sclerosis","volume":"37","author":"Fullard","year":"2015","journal-title":"Semin. Immunopathol."},{"issue":"7761","key":"10.1016\/j.ejmech.2023.115784_bib3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41586-019-1295-z","article-title":"Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome","volume":"570","author":"Sharif","year":"2019","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ejmech.2023.115784_bib4","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ni.3015","article-title":"RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway","volume":"15","author":"Wang","year":"2014","journal-title":"Nat. Immunol."},{"issue":"7081","key":"10.1016\/j.ejmech.2023.115784_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature04515","article-title":"Cryopyrin activates the inflammasome in response to toxins and ATP","volume":"440","author":"Mariathasan","year":"2006","journal-title":"Nature"},{"issue":"7081","key":"10.1016\/j.ejmech.2023.115784_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ejmech.2023.115784_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ni.2231","article-title":"Sensing and reacting to microbes through the inflammasomes","volume":"13","author":"Franchi","year":"2012","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.ejmech.2023.115784_bib8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/intimm\/dxx018","article-title":"Mechanisms governing inflammasome activation, assembly and pyroptosis induction","volume":"29","author":"Kesavardhana","year":"2017","journal-title":"Int. Immunol."},{"issue":"9","key":"10.1016\/j.ejmech.2023.115784_bib9","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ejmech.2023.115784_bib10","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological inhibitors of the NLRP3 inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Front. Immunol."},{"issue":"7434","key":"10.1016\/j.ejmech.2023.115784_bib11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejmech.2023.115784_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.ejmech.2023.115784_bib13","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1183\/09031936.00158110","article-title":"Role of IL-1alpha and the Nlrp3\/caspase-1\/IL-1beta axis in cigarette smoke-induced pulmonary inflammation and COPD","volume":"38","author":"Pauwels","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.ejmech.2023.115784_bib14","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.4049\/jimmunol.1000217","article-title":"Cutting edge: critical role for PYCARD\/ASC in the development of experimental autoimmune encephalomyelitis","volume":"184","author":"Shaw","year":"2010","journal-title":"J. Immunol."},{"issue":"7293","key":"10.1016\/j.ejmech.2023.115784_bib15","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ejmech.2023.115784_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3892\/ijmm.2023.5238","article-title":"Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases","volume":"51","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115784_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2163838","article-title":"An IBD-associated pathobiont synergises with NSAID to promote colitis which is blocked by NLRP3 inflammasome and Caspase-8 inhibitors","volume":"15","author":"Singh","year":"2023","journal-title":"Gut Microb."},{"issue":"7","key":"10.1016\/j.ejmech.2023.115784_bib18","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1021\/acs.jmedchem.3c00175","article-title":"Novel aryl sulfonamide derivatives as NLRP3 inflammasome inhibitors for the potential treatment of cancer","volume":"66","author":"Albanese","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115784_bib19","doi-asserted-by":"crossref","first-page":"1204143","DOI":"10.3389\/fonc.2023.1204143","article-title":"RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist","volume":"13","author":"Oronsky","year":"2023","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.ejmech.2023.115784_bib20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115784_bib21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.molcel.2012.11.009","article-title":"Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity","volume":"49","author":"Py","year":"2013","journal-title":"Mol. Cell."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115784_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molcel.2017.08.017","article-title":"NLRP3 phosphorylation is an essential priming event for inflammasome activation","volume":"68","author":"Song","year":"2017","journal-title":"Mol. Cell."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115784_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1083\/jcb.200903124","article-title":"Glyburide inhibits the Cryopyrin\/Nalp3 inflammasome","volume":"187","author":"Lamkanfi","year":"2009","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.ejmech.2023.115784_bib24","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/mnfr.201600106","article-title":"Epigallocatechin gallate inhibits urate crystals-induced peritoneal inflammation in C57BL\/6 mice","volume":"60","author":"Jhang","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ejmech.2023.115784_bib25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.abb.2019.01.031","article-title":"The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in Gout","volume":"670","author":"Szekanecz","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"issue":"7904","key":"10.1016\/j.ejmech.2023.115784_bib26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41586-022-04467-w","article-title":"Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3","volume":"604","author":"Hochheiser","year":"2022","journal-title":"Nature"},{"issue":"Pt 1","key":"10.1016\/j.ejmech.2023.115784_bib27","article-title":"Recent advances in gout drugs","volume":"245","author":"Shi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115784_bib28","doi-asserted-by":"crossref","first-page":"8618","DOI":"10.1038\/s41598-018-26775-w","article-title":"MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice","volume":"8","author":"Perera","year":"2018","journal-title":"Sci Rep-Uk"},{"issue":"1","key":"10.1016\/j.ejmech.2023.115784_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/acs.jmedchem.0c01307","article-title":"Strategies for targeting the NLRP3 inflammasome in the clinical and preclinical space","volume":"64","author":"Schwaid","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115784_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.csite.2023.103029","article-title":"Advanced modeling based on machine learning for evaluation of drug nanoparticle preparation via green technology: theoretical assessment of solubility variations","volume":"45","author":"Begum","year":"2023","journal-title":"Case Stud. Therm. Eng."},{"issue":"5","key":"10.1016\/j.ejmech.2023.115784_bib31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/10509674.2023.2213693","article-title":"Applied machine learning analysis: factors correlated with injection drug use and post-prison medication for opioid use disorder treatment engagement","volume":"62","author":"Victor","year":"2023","journal-title":"J. Offender Rehabil."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115784_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/FTD.0000000000001078","article-title":"Artificial intelligence and machine learning approaches to facilitate therapeutic drug management and model-informed precision dosing","volume":"45","author":"Poweleit","year":"2023","journal-title":"Ther. Drug Monit."},{"issue":"8","key":"10.1016\/j.ejmech.2023.115784_bib33","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1158\/0008-5472.CAN-22-1910","article-title":"Bayesian machine learning enables identification of transcriptional network disruptions associated with drug-resistant prostate cancer","volume":"83","author":"Blatti","year":"2023","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115784_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12859-022-05076-0","article-title":"Machine learning and drug discovery for neglected tropical diseases","volume":"24","author":"Breslin","year":"2023","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ejmech.2023.115784_bib35","first-page":"1","article-title":"In silico drug repurposing by combining machine learning classification model and molecular dynamics to identify a potential OGT inhibitor","volume":"13","author":"Azevedo","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115784_bib36","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1021\/acs.jmedchem.0c01924","article-title":"Development of novel tetrahydroquinoline inhibitors of NLRP3 inflammasome for potential treatment of DSS-induced mouse colitis","volume":"64","author":"Dai","year":"2021","journal-title":"J. Med. Chem."},{"issue":"7775","key":"10.1016\/j.ejmech.2023.115784_bib37","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-019-1551-2","article-title":"DDX3X acts as a live-or-die checkpoint in stressed cells by regulating NLRP3 inflammasome","volume":"573","author":"Samir","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejmech.2023.115784_bib38","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.apsb.2022.09.014","article-title":"Costunolide covalently targets NACHT domain of NLRP3 to inhibit inflammasome activation and alleviate NLRP3-driven inflammatory diseases","volume":"13","author":"Xu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.ejmech.2023.115784_bib39","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/13880209.2023.2208617","article-title":"Qiqilian ameliorates vascular endothelial dysfunction by inhibiting NLRP3-ASC inflammasome activation in vivo and in vitro","volume":"61","author":"Luo","year":"2023","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ejmech.2023.115784_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113417","article-title":"Discovery of chalcone analogues as novel NLRP3 inflammasome inhibitors with potent anti-inflammation activities","volume":"219","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115784_bib41","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00296-023-05301-w","article-title":"Differential diagnosis of tophaceous Gout and multiple facial papules in Federico da Montefeltro by Piero della Francesca (c. 1415-1492)","volume":"43","author":"Ashrafian","year":"2023","journal-title":"Rheumatol. Int."},{"issue":"11","key":"10.1016\/j.ejmech.2023.115784_bib42","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1136\/annrheumdis-2011-200908","article-title":"Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions","volume":"71","author":"Schlesinger","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.ejmech.2023.115784_bib43","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.4049\/jimmunol.1801097","article-title":"Leptin promotes monosodium urate crystal-induced inflammation in human and murine models of gout","volume":"202","author":"Yu","year":"2019","journal-title":"J. Immunol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423007511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423007511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:01:35Z","timestamp":1759330895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423007511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":43,"alternative-id":["S0223523423007511"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115784","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of NLRP3 inhibitors using machine learning: Identification of a hit compound to treat NLRP3 activation-driven diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115784"}}